Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Enablex (darifenacin) Treatment Report
What is Enablex?

Enablex is a brand name for the drug darifenacin. It is an extended release preparation that is used for the management of symptoms of bladder overactivity (urge incontinence, urgency, and frequency).

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Bladder problems 28 2
Urinary frequency 5 0
Urinary urgency 5 0
Other 2 0
loss of bladder control often 1 0
Slow my MS progress 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
2 100%
None
0 0%

Most commonly reported side effects

slows down starting urination
1 50%
Constipation
1 50%
Dry mouth (xerostomia)
1 50%
  • Mild
  • Moderate
  • Severe

Dosages

  15mg as needed daily 7.2 mg daily 7.5 mg daily 15 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 16 Number of Patients: 16 16 Number of Patients: 16  

Stop Reasons

Why Patients Stopped Taking Enablex (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
5 63% Did not seem to work: 63%
Expense
3 38% Expense: 38%
Personal research
1 13% Personal research: 13%
Doctor's advice
1 13% Doctor's advice: 13%

See all 8 patients who’ve stopped taking Enablex

Currently Taking Enablex

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
1
3
8
8

Stopped Taking Enablex

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
3
3
0
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
2 100%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.